PACS Group (NYSE:PACS – Get Free Report) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.
Other analysts have also recently issued research reports about the company. Oppenheimer lifted their target price on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. JPMorgan Chase & Co. upped their target price on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Weiss Ratings raised PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, November 4th. Truist Financial restated a “buy” rating and set a $65.00 price target (up from $62.00) on shares of PACS Group in a research note on Thursday, November 5th. Finally, Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Seven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, PACS Group currently has an average rating of “Moderate Buy” and a consensus price target of $62.50.
Check Out Our Latest Stock Report on PACS
PACS Group Trading Up 1.4%
PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.05. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. On average, sell-side analysts expect that PACS Group will post 2.05 earnings per share for the current fiscal year.
Insider Buying and Selling at PACS Group
In other PACS Group news, Director Mark Hancock sold 186,696 shares of the firm’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at approximately $2,689,937,697.80. This trade represents a 0.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Lewis sold 3,172 shares of PACS Group stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total transaction of $158,790.32. Following the completion of the transaction, the chief accounting officer owned 340,338 shares in the company, valued at approximately $17,037,320.28. This represents a 0.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,395,000 shares of company stock worth $64,793,252 in the last 90 days. Company insiders own 70.10% of the company’s stock.
Institutional Investors Weigh In On PACS Group
Hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP grew its position in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after buying an additional 614,250 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in PACS Group during the 2nd quarter worth $8,196,000. Principal Financial Group Inc. purchased a new position in PACS Group during the 1st quarter worth $3,171,000. Arrowstreet Capital Limited Partnership raised its position in PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after buying an additional 89,067 shares during the last quarter. Finally, Cantor Fitzgerald Investment Advisors L.P. acquired a new stake in shares of PACS Group in the 3rd quarter worth $1,920,000.
About PACS Group
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Further Reading
- Five stocks we like better than PACS Group
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
